Isolates from hospital environments are the most virulent of the Candida parapsilosis complex

BMC Microbiology

Volumn 11, Issue , 2011, Pages

  Sabino, Raquel ^a,b   Sampaio, Paula ^a   Carneiro, Catarina ^a   Rosado, Laura ^b   Pais, Célia ^a  

^a UNIVERSITY OF MINHO   (Portugal)

^b NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROLASE; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ARTICLE; CANDIDA METAPSILOSIS; CANDIDA ORTHOPSILOSIS; CANDIDA PARAPSILOSIS; CELL DAMAGE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; ENZYME RELEASE; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGUS HYPHAE; HOSPITAL; HUMAN; MACROPHAGE; NONHUMAN; CANDIDA; CANDIDIASIS; CELL SURVIVAL; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOGENICITY; SECRETION;

CANDIDA PARAPSILOSIS;

CANDIDA; CANDIDIASIS; CELL DEATH; CELL SURVIVAL; CYTOKINES; ENVIRONMENTAL MICROBIOLOGY; HOSPITALS; HUMANS; MACROPHAGES;

EID: 79961113241     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-11-180     Document Type: Article

References (42)

1. Emergence of non Candida albicans Candida species as pathogens. Moran GP, Sullivan DJ, Coleman DC, Candida and Candidiasis Washington DC: ASM Press, Calderone RA, 2002 341 348
2. Epidemiology, risk factors and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. Almirante B, Rodriguez D, Cuenca-Estrella M, Almela M, Sanchez F, Ayats J, Alonso-Tarres C, Rodriguez-Tudela JL, Pahissa A, the Barcelona Candidemia Project Study Group, J Clin Microbiol 2006 44 1681 1685 10.1128/JCM.44.5.1681-1685.2006 16672393 (Pubitemid 43726255)
3. A first Portuguese epidemiological survey of fungaemia in a university hospital. Costa-de-Oliveira S, Pina-Vaz C, Mendonça D, Rodrigues AG, Eur J Clin Microbiol Infect Dis 2008 27 365 374 10.1007/s10096-007-0448-4 18204871
4. Candida parapsilosis, an emerging fungal pathogen. Trofa D, Gácser A, Nosanchuk JD, Clin Microbiol Rev 2008 21 606 625 10.1128/CMR.00013-08 18854483
5. Candida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing, and antimicrobial susceptibility. van Asbeck EC, Clemons KV, Stevens DA, Crit Rev Microbiol 2009 35 283 309 10.3109/ 10408410903213393 19821642
6. Epidemiology of candidemia in oncology patients: a 6-year survey in a Portuguese central hospital. Sabino R, Veríssimo C, Brandão J, Alves C, Parada H, Rosado L, Paixão E, Videira Z, Tendeiro T, Sampaio P, Pais C, Med Mycol 2010 48 346 54 10.3109/13693780903161216 19657956
7. Risk factors for candidemia in neonatal intensive care unit patients. The National Epidemiology of Mycosis Survey Study Group. Saiman L, Ludington E, Pfaller M, Rangel-Frausto S, Wiblin RT, Dawson J, Blumberg HM, Patterson JE, Rinaldi M, Edwards JE, Wenzel RP, Jarvis W, Pediatr Infect Dis J 2000 19 319 24 10.1097/00006454-200004000-00011 10783022 (Pubitemid 30213071)
8. The role of birth weight and gestational age in distinguishing extremely low birth weight infants at high risk of developing candidemia from infants at low risk: a multicenter study. Karlowicz MG, Rowen JL, Barnes-Eley ML, Burke BL, Lawson ML, Bendel CM, Shattuck KE, Horgan M, Albritton WL, Pediatr Res 2002 51 301A
9. Candida parapsilosis infection in very low birthweight infants. Clerihew L, Lamagni TL, Brocklehurst P, McGuire W, Arch Dis Child Fetal Neonatal Ed 2007 92 127 F129 10.1136/fnn.2006.097758 17337658 (Pubitemid 46423826)
10. Environmental surveillance and other control measures in the prevention of nosocomial fungal infections. Muoz P, Burillo A, Pouza E, Clin Microbiol Infect 2001 7 38 45 10.1111/j.1469-0691.2001.tb00008.x 11525217
11. A prospective survey of air and surface fungal contamination in a medical mycology laboratory at a tertiary care university hospital. Sautour M, Dalle F, Olivieri C, L'ollivier C, Enderlin E, Salome E, Chovelon I, Vagner O, Sixt N, Fricker-Pap V, Aho S, Fontaneau O, Cachia C, Bonnin A, Am J Infect Control 2009 37 189 194 10.1016/j.ajic.2008.06.009 19059674
12. Outbreak of fungemia due to Candida parapsilosis in a pediatric oncologic unit. Barchesi F, Caggiano G, Falconi Di Francesco L, Montagna MT, Barbuti S, Scalise G, Diagn microbial Infect Dis 2004 49 269 271 10.1016/j.diagmicrobio. 2004.03.011 (Pubitemid 39094618)
13. Candida parapsilosis fungemia in neonates: genotyping results suggest healthcare workers hands as source, and review of published studies. van Asbeck EC, Huang Y-C, Markham AN, Clemons KV, Stevens DA, Mycophatologia 2007 164 287 293 10.1007/s11046-007-9054-3 (Pubitemid 47622127)
14. Secreted lipases of Candida albicans: cloning, characterisation and expression analysis of a new gene family with at least ten members. Hube B, Stehr F, Bossenz M, Mazur A, Kretschmar M, Schäfer W, Arch Microbiol 2000 174 362 374 10.1007/s002030000218 11131027
15. Candida parapsilosis characterization in an outbreak setting. Khun DM, Mikherjee PK, Clark TA, Pujol C, Chandra J, Hajjeh RA, Warnock DW, Soil DR, Ghannoum MA, Emerg Infect Dis 2004 10 1074 1081 15207060 (Pubitemid 38697701)
16. Comparison of proteinase, lipase and alpha-glucosidase activities from the clinical isolates of Candida species. Bramono K, amazaki M, Tsuboi R, Ogawa H, Jpn J Infec Dis 2006 59 73 76
17. Endothelial cells potentiate phagocytic killing by macrophages via platelet-activating factor release. Owaki T, Meneshian A, Maemura K, Takao S, Wang D, Fuh KC, Bulkley GB, Klein AS, Am J Physiol Heart Circ Physiol 2000 278 269 H276 10644608
18. Targeted gene deletion in Candida parapsilosis demonstrates the role of secreted lipase in virulence. Gácser A, Trofa D, Schäfer W, Nosanchuk JD, J Clin Invest 2007 117 3049 3058 10.1172/JCI32294 17853941 (Pubitemid 47529634)
19. Virulence of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis in reconstituted human tissue models. Gácser A, Schafer W, Nosanchuk JS, Salomon S, Nosanchuk JD, Fungal Genet Biol 2007 44 1336 1341 10.1016/j.fgb.2007.02.002 17391997 (Pubitemid 350046346)
20. Enhancement of macrophage candidacidal activity by interferon-y-increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors. Marádi L, Schreiber S, Anderson DC, MacDermott RP, Korchak HM, Johnston RB Jr, J Clin Invest 1993 91 2596 2601 10.1172/JCI116498 8390485 (Pubitemid 23182514)
21. Modulation of macrophage cytokine profiles during solid tumor progression: susceptibility to Candida albicans infection. Camargo MR, Venturini J, Vilani-Moreno FR, Arruda MSP, BMC Infectious Diseases 2009 9 98 106 10.1186/1471-2334-9-98 19534779
22. Life and death in a macrophage: role of the glyoxylate cycle in virulence. Lorenz MC, Fink GR, Eukaryot Cell 2002 1 657 662 10.1128/EC.1.5.657- 662.2002 12455685 (Pubitemid 36557725)
23. Candida metapsilosis as the least virulent member of the C. parapsilosis complex. Orsi CF, Colombari B, Blasi E, Med Mycol 2010 48 1024 1033 10.3109/13693786.2010.489233 20507266
24. Alterations of protein expression in macrophages in response to Candida albicans infection. Shin YK, Kim KY, Paik YK, Mol Cells 2005 20 271 279 16267403
25. Candida albicans isolates with different genomic backgrounds display a differential response to macrophage infection. Tavanti A, Campa D, Bertozzi A, Pardini G, Naglik JR, Barale R, Senesi S, Microbes Infect 2006 8 791 800 10.1016/j.micinf.2005.09.016 16473540
26. Expression analysis of the Candida albicans lipase gene family during experimental infections and in patient samples. Stehr F, Gácser A, Kretschmar M, Mähnss B, Neuber K, Hube B, Schäfer W, FEMS Yeast Res 2004 4 401 408 10.1016/S1567-1356(03)00205-8 14734020 (Pubitemid 38156204)
27. Hydrolytic enzymes as virulence factors of Candida albicans. Schaller M, Borelli C, Korting HC, Hube B, Mycoses 2005 48 365 377 10.1111/j.1439-0507.2005. 01165.x 16262871 (Pubitemid 43942679)
28. Biotyping and virulence properties of skin isolates of Candida parapsilosis. De Bernardis F, Mondello F, San Millán R, Pontán J, Cassone A, J Clin Microbiol 1999 37 3481 3486 10523538 (Pubitemid 29491078)
29. Secreted aspartic proteases of Candida albicans, Candida tropicalis, Candida parapsilosis and Candida lusitaniae. Pichová I, Pavlicková L, Dostál J, Dolejsí E, Hrusková-Heidingsfeldová O, Weber J, Ruml T, Soucek M, Eur J Biochem 2001 268 2669 2677 10.1046/j.1432-1327.2001.02152.x 11322888 (Pubitemid 32853006)
30. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Khun D, Chandra J, Mukherjee PK, Ghannoum MA, Infect Immun 2002 70 878 888 10.1128/IAI.70.2.878-888.2002 11796623 (Pubitemid 34083852)
31. Slime production and proteinase activity of Candida species isolated from blood samples and the comparison of these activities with minimum inhibitory concentration values of antifungal agents. Ozkan S, Kaynak F, Kalkanci A, Abbasoglu U, Kustimur S, Mem Inst Oswaldo Cruz 2005 100 319 324 10.1590/S0074-02762005000300019 16113876
32. Acid proteinase, phospholipase, and adherence properties of Candida parapsilosis strains isolated fron clinical specimens of hospitalized patients. Dagdeviren M, Cerikcioglu N, Karavus M, Mycoses 2005 48 321 326 10.1111/j.1439-0507.2005.01145.x 16115102 (Pubitemid 41656978)
33. Three distinct genotypes within Candida parapsilosis from clinical sources. Lin DM, Wu LC, Rinaldi MG, Lehmann PF, J Clin Microbiol 1995 33 1815 1821 7665651
34. Interactions of Toll-like receptors with fungi. Levitz SM, Microb Infect 2004 6 1351 1355 10.1016/j.micinf.2004.08.014 (Pubitemid 41110576)
35. Immunity to fungal infections. Romani L, Nat Rev Immunol 2004 4 11 24 10.1038/nri1255
36. Receptors and pathways in innate antifungal immunity: the implication for tolerance and immunity to fungi. Zelante T, Montagnoli C, Bozza S, Gaziano R, Bellocchio S, Bonifazi P, Moretti S, Fallarino F, Puccetti P, Romani L, Adv Exp Med Biol 2007 590 209 221 10.1007/978-0-387-34814-8-15 17191388
37. Occurrence and genetic variability of Candida parapsilosis sensu lato in Hungary. Kocsubé S, Táth M, Vágvölgyi C, Dáczi I, Pesti M, Pácsi I, Szabá J, Varga J, J Med Microbiol 2007 56 Pt 2 190 5 17244799
38. AFLP genotyping of Candida metapsilosis clinical isolates: Evidence for recombination. Hensgens LA, Tavanti A, Mogavero S, Ghelardi E, Senesi S, Fungal Genet Biol 2009 46 10 750 758 10.1016/j.fgb.2009.06.006 19559094
39. Characterization of the Oral Fungal Microbiome (Mycobiome) in Healthy Individuals. Ghannoum MA, Jurevic RJ, Mukherjee PK, Cui F, Sikaroodi M, Naqvi A, Gillevet PM, PLoS Pathog 2010 6 1 1000713 10.1371/journal.ppat.1000713 20072605
40. New polymorphic microsatellite markers able to distinguish among. Candida parapsilosis senso stricto isolates. Sabino R, Sampaio P, Rosado L, Stevens DA, Clemons KV, Pais C, J Clin Microbiol 2010 48 1677 1682 10.1128/JCM.02151-09 20220157
41. Polyphasic taxonomy of the basidiomycetous yeast genus Rhodosporidium: Rhodosporidium kratochvilovae and related anamorphic species. Sampaio JP, Gadanho M, Santos M, Duarte FL, Pais C, Fonseca A, Fell JW, Int J Syst Evol Microbiol 2001 51 687 697 11321116 (Pubitemid 32266712)
42. Isolation and characterization of Candida spp. in Jordanian cancer patients: prevalence, pathogenic determinants and antifungal sensitivity. Al-Abeid H, Abu-Elteen K, Elkarmi A, Hamad M, Jpn J Infect Dis 2004 57 279 284 15623957 (Pubitemid 40260248)